Literature DB >> 9015208

The physico-chemical factors that govern retrovirus-mediated gene transfer.

B Palsson1, S Andreadis.   

Abstract

The most commonly used vehicle for gene transfer into human target cells is a replication incompetent retroviral vector. The efficiency of gene transfer with this type of vector has proven to be too low to implement effective gene therapy. To date much effort has gone into engineering the genetic and biochemical functionalities of retroviral vectors. Although progress has been achieved, high-efficiency reproducible gene transfer into human cells remains elusive. There are many important physico-chemical and systemic kinetic factors that govern the process of retrovirus-mediated gene transfer. These factors have gone mostly unrecognized to date. The former include the nature of the random Brownian motion of the retrovirus and the physico-chemical forces that determine the binding of the retroviral vector to the target cell. The latter arise from the kinetics of virus binding and entry into the target cell, as well as the kinetic interplay between cell-cycle and retroviral life-cycle events that determine the intracellular fate of the virus. This review describes these processes and how they constrain the efficiency of the gene transfer process.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9015208

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  9 in total

1.  Production of lentiviral vectors for transducing cells from the central nervous system.

Authors:  Mingjie Li; Nada Husic; Ying Lin; B Joy Snider
Journal:  J Vis Exp       Date:  2012-05-24       Impact factor: 1.355

2.  Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding.

Authors:  U O'Doherty; W J Swiggard; M H Malim
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Cell targeting in anti-cancer gene therapy.

Authors:  Mohd Azmi Mohd Lila; John Shia Kwong Siew; Hayati Zakaria; Suria Mohd Saad; Lim Shen Ni; Jafri Malin Abdullah
Journal:  Malays J Med Sci       Date:  2004-01

4.  Primary attachment of murine leukaemia virus vector mediated by particle-associated heparan sulfate proteoglycan.

Authors:  Nina Kureishy; Daisy Faruque; Colin D Porter
Journal:  Biochem J       Date:  2006-12-15       Impact factor: 3.857

5.  Human immunodeficiency virus type 1 neutralization measured by flow cytometric quantitation of single-round infection of primary human T cells.

Authors:  John R Mascola; Mark K Louder; Christine Winter; Ranjani Prabhakara; Stephen C De Rosa; Daniel C Douek; Brenna J Hill; Dana Gabuzda; Mario Roederer
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

6.  Envelope-dependent, cyclophilin-independent effects of glycosaminoglycans on human immunodeficiency virus type 1 attachment and infection.

Authors:  Yi-Jun Zhang; Theodora Hatziioannou; Trinity Zang; Douglas Braaten; Jeremy Luban; Stephen P Goff; Paul D Bieniasz
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

7.  Transduction of Schistosoma japonicum schistosomules with vesicular stomatitis virus glycoprotein pseudotyped murine leukemia retrovirus and expression of reporter human telomerase reverse transcriptase in the transgenic schistosomes.

Authors:  Shenghui Yang; Paul J Brindley; Qingren Zeng; Yuesheng Li; Jun Zhou; Yan Liu; Biyuan Liu; Liting Cai; Tiebing Zeng; Qi Wei; Lingmei Lan; Donald P McManus
Journal:  Mol Biochem Parasitol       Date:  2010-08-06       Impact factor: 1.759

8.  Retrovirus-associated heparan sulfate mediates immobilization and gene transfer on recombinant fibronectin.

Authors:  Pedro Lei; Bharat Bajaj; Stelios T Andreadis
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

9.  Single-nucleotide variants in human CD81 influence hepatitis C virus infection of hepatoma cells.

Authors:  María Pía Alberione; Rebecca Moeller; Jared Kirui; Corinne Ginkel; Mandy Doepke; Luisa J Ströh; Jan-Philipp Machtens; Thomas Pietschmann; Gisa Gerold
Journal:  Med Microbiol Immunol       Date:  2020-04-22       Impact factor: 3.402

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.